We thank all our partners for their kind support.
AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization's efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.
AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.
Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.”
The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world's largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.
The first small patient ever given Henri Nestlé's "infants' flour" was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.
Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby's health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both - and Philips AVENT will support her in whatever choice she makes.
Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.
Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.
Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.
Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!
You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?
Become a Partner of EFCNI!
Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.